VESTILABS

VESTILABS is an innovative medtech startup revolutionizing the management of acute vertigo attacks with a groundbreaking, self-administered, connected medical spray. This innovative device empowers patients to manage their symptoms autonomously at home, offering a non-invasive and effective alternative to traditional treatments such as intravenous injections. By improving patient autonomy, reducing the strain on healthcare systems, and making vertigo treatment more accessible, our solution has the potential to transform the standard of care for vertigo patients worldwide. Currently, VestiLabs is at an advanced prototype stage, with the next major milestone being CE certification. Founded in May 2022 by Thierry Miséré, and now co-led with Bertrand Gili, our mission is to deliver impactful and patient-focused medical innovations that enhance quality of life and address unmet healthcare needs. In Short: At VestiLabs, we’re transforming vertigo care with a self-administered, connected medical spray that empowers patients, reduces healthcare burdens, and improves accessibility. Currently advancing toward CE certification, we’re driven by innovation and a commitment to improving patient lives.